TIMELINE: The tumultuous 155-year history of oil prices

Most recently, after two years of depressed prices, OPEC agreed to curtail output by 1.2 million barrels per day at its meeting in Vienna in late November in an attempt to end the global supply glut. Several non-OPEC producers including Russia tagged along in December, agreeing to reduce output by about 560,000 bpd .

Dalton Wins U.S. Army Contract

Dalton Pharma Services has entered into a contract service agreement with the United States Army Medical Materiel Development Activity to support its product development program for the treatment of severe or complicated malaria due to Plasmodium falciparum. Dalton will provide cGMP sterile powder filling, aseptic liquid filling, quality control release testing and ICH stability services.

Health Highlights: Dec. 20, 2016

The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment.

Literatus: Narcolepsy at a high place?

… are working night shifts in business process outsourcing companies, such as call centers. Google brought me a 2008 health advice column by two physicians who responded to a reader’s query on similar symptoms: “This can happena most embarrassingly, …

FAO: Horn of Africa Braces for Another Hunger Season [video]

Growing numbers of refugees in East Africa, meanwhile, are expected to place even more burden on already strained food and nutrition security. Currently, close to 12 million people across Ethiopia, Kenya and Somalia are in need of food assistance, as families in the region face limited access to food and income, together with rising debt, low cereal and seed stocks, and low milk and meat production.

Under Trump, America Will Turn Into Poland? Nahhh — America Will Be Worse.

In The Washington Post , Anthony Faiola describes what’s happening in Poland, and strongly suggests that America under Donald Trump could be very similar: In the land of [the] Law and Justice [Party], anti-intellectualism is king. Polish scientists are aghast at proposed curriculum changes in a new education bill that would downplay evolution theory and climate change and add hours for “patriotic” history lessons.

Akebia sells rights to anemia drug to Japan’s Otsuka

Drug developer Akebia Therapeutics Inc said on Tuesday it had signed a co-development and marketing deal worth up to $1 billion with Japan’s Otsuka Holdings Co Ltd. Akebia said the deal would give it the funds needed to develop vadadustat, its experimental drug to treat anemia associated with chronic kidney disease. Akebia’s shares were up 17.1 percent at $9.78 in early trading.

Beer company touts higher alcohol content in Milwaukee ads

Miller Coors says advertisements touting the alcohol content of one of its cheapest beers are aimed at transparency so consumers can make informed choices. The Milwaukee Journal Sentinel reports billboards along the city’s freeways say the alcohol content of Milwaukee’s Best Ice is now 6.9 percent, up from 5.9 percent.

Mumps hitting state’s Marshallese hard

The breadth of the outbreak of mumps in Northwest Arkansas appears to be linked in part to that area’s community of Marshall Islanders, the director of the state Department of Health said Monday. Meanwhile, the region’s high rate of unvaccinated schoolchildren compared with the rest of the state doesn’t appear to be a factor in the unusual size of the outbreak, said Nate Smith, director of the state Department of Health.

Study identifies four previously unknown genetic risk locations for primary sclerosing cholangitis

A study of unprecedented scale has led researchers to identify four previously unknown genetic risk locations for primary sclerosing cholangitis, a liver disease that lacks effective medical therapy. A Dec. 19 article in Nature Genetics highlights the undertaking, which is the largest genome-wide association study of primary sclerosing cholangitis to date and a step toward providing breakthrough treatments for the unmet needs of primary sclerosing cholangitis patients.

Fischer Laser Eye Center Opens New Office in Benson, Minnesota

The doctors of Fischer Laser Eye Center will begin seeing patients at their new office in Benson, Minnesota, starting January 2017. In January of 2017, the family eye doctors of Fischer Laser Eye Center will begin seeing patients at their new Benson, Minnesota, office located inside the recently constructed DoMats grocery store on 1705 Minnesota Avenue .

Blog: Where is the TV camera?

With Christmas fast approaching, the inflation of charitable events has been taking over Slovakia. Yes, it’s that time of the year when I wish people noticed that children’s hospitals have more wards than the “oncology” one.

SP Scientific webinar shows improvements in lyophilization through ControLyoa Technology

SP Scientific announces the on-demand availability of a popular webinar** by Jake Luoma of Genentech Inc. that discusses how controlled nucleation has emerged as a technology which promises improvements in lyophilization process throughput and consistency. In this presentation, Mr. Luoma examines the benefits of the technology for high fill-volume configurations and presents new data regarding the mechanism of the ControLyo Technology.

New graphene system can detect activity levels of interfaced normal and cancer cells

By interfacing brain cells onto graphene, researchers at the University of Illinois at Chicago have shown they can differentiate a single hyperactive cancerous cell from a normal cell, pointing the way to developing a simple, noninvasive tool for early cancer diagnosis. “This graphene system is able to detect the level of activity of an interfaced cell,” says Vikas Berry, associate professor and head of chemical engineering at UIC, who led the research along with Ankit Mehta, assistant professor of clinical neurosurgery in the UIC College of Medicine.

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib…

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein. Anacetrapib , an inhibitor of cholesteryl ester transfer protein activity, increases plasma concentrations of high-density lipoprotein cholesterol , apolipoprotein A-I -I, apoA-II, and CETP.

Lasers a transforma prostate treatment

The approach, tested across Europe, uses lasers and a drug made from deep sea bacteria to eliminate tumours, but without causing severe side effects. Trials on 413 men published in The Lancet Oncology showed nearly half of them had no remaining trace of cancer.